Clinical Trials Browser

Phase 2/3 × Rosuvastatin Calcium × 90 days × Clear all

NCT07504198 2026-03-31

Neuroprotection of Memantine and Rosuvastatin

Phase 2/3 Not yet recruiting

Peripheral Nervous System Diseases